These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 2904525)
41. Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy. Rothstein JD; Olasmaa M Neurochem Res; 1990 Feb; 15(2):193-7. PubMed ID: 2159124 [TBL] [Abstract][Full Text] [Related]
42. Beneficial effect of pharmacological modulation of the GABAA-benzodiazepine receptor on hepatic encephalopathy in the rat: comparison with uremic encephalopathy. Steindl P; Püspök A; Druml W; Ferenci P Hepatology; 1991 Dec; 14(6):963-8. PubMed ID: 1660024 [TBL] [Abstract][Full Text] [Related]
44. [The quantitative electroencephalogram in a case of acute hepatic encephalopathy treated with flumazenil]. Frenkel AL; Hermant JL; Blaise M; Volter F; Pourriat JL Cah Anesthesiol; 1991; 39(1):61-2. PubMed ID: 2054699 [No Abstract] [Full Text] [Related]
45. Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis. Goulenok C; Bernard B; Cadranel JF; Thabut D; Di Martino V; Opolon P; Poynard T Aliment Pharmacol Ther; 2002 Mar; 16(3):361-72. PubMed ID: 11876688 [TBL] [Abstract][Full Text] [Related]
46. An interaction between benzodiazepines and neuroactive steroids at GABA A receptors in cultured hippocampal neurons. Ahboucha S; Coyne L; Hirakawa R; Butterworth RF; Halliwell RF Neurochem Int; 2006 Jun; 48(8):703-7. PubMed ID: 16487630 [TBL] [Abstract][Full Text] [Related]
47. The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: a double-blind placebo-controlled study. Amodio P; Marchetti P; Del Piccolo F; Beghi A; Comacchio F; Carraro P; Campo G; Baruzzo L; Marchiori C; Gatta A Clin Physiol; 1997 Sep; 17(5):533-9. PubMed ID: 9347201 [TBL] [Abstract][Full Text] [Related]
48. Is flumazenil an alternative for the treatment of hepatic encephalopathy? Reyes D; Barrera F Medwave; 2017 Dec; 17(9):e7113. PubMed ID: 29286356 [TBL] [Abstract][Full Text] [Related]
49. [Acute effect of flumazenil in refractory hepatic encephalopathy]. Chesta J; Brahm J; Poniachik J Rev Med Chil; 1989 Sep; 117(9):1049-50. PubMed ID: 2519472 [No Abstract] [Full Text] [Related]
50. [Mixed benzodiazepine poisoning and reversal with flumazenil (Ro 15-1788)]. Rivas López FA; López Soriano F; Mendoza Cerezo A; Jiménez Ferré J; Azurmendi Rodríguez JI; de la Rubia Nieto MA Rev Esp Anestesiol Reanim; 1989; 36(1):48-50. PubMed ID: 2565591 [TBL] [Abstract][Full Text] [Related]
52. Hepatic encephalopathy and role of antibenzodiazepines. Hammond JB; Ahmad F Am J Ther; 1998 Jan; 5(1):33-6. PubMed ID: 10099035 [TBL] [Abstract][Full Text] [Related]
53. Reversible hepatic decerebration: a case report and review of the literature. Wehbe E; Saad D; Delgado F; Ta H; Antoun SA Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):759-60. PubMed ID: 19521243 [TBL] [Abstract][Full Text] [Related]
54. [Specific therapy of acute benzodiazepine poisoning using flumazenil (Ro 15-1788)]. Hruby K; Prischl F; Smetana R; Pernecker M; Donner A; Scholtz I; Grimm G Wien Med Wochenschr; 1987 May; 137(9):179-83. PubMed ID: 2885978 [TBL] [Abstract][Full Text] [Related]
55. [Flumazenil in the treatment of hepatic encephalopathy]. Pintanel T; Font MM; García-Guasch R Med Clin (Barc); 1990 Jun; 95(4):157. PubMed ID: 2250539 [No Abstract] [Full Text] [Related]
57. Benzodiazepine receptor antagonism improves reaction time in latent hepatic encephalopathy. Gooday R; Hayes PC; Bzeizi K; O'Carroll RE Psychopharmacology (Berl); 1995 Jun; 119(3):295-8. PubMed ID: 7675964 [TBL] [Abstract][Full Text] [Related]
58. Role of endogenous benzodiazepine ligands and their GABA-A--associated receptors in hepatic encephalopathy. Ahboucha S; Butterworth RF Metab Brain Dis; 2005 Dec; 20(4):425-37. PubMed ID: 16382352 [TBL] [Abstract][Full Text] [Related]
59. The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands. Basile AS; Jones EA; Skolnick P Pharmacol Rev; 1991 Mar; 43(1):27-71. PubMed ID: 1674609 [No Abstract] [Full Text] [Related]